tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:2696 Stock Latest News

Henlius Reshapes Global Licensing Strategy for HANSIZHUANG With Abbott and KGBio
Company AnnouncementsHenlius Reshapes Global Licensing Strategy for HANSIZHUANG With Abbott and KGBio
1d ago
2696
Henlius Wins U.S. FDA IND Nod for Multiple Myeloma Biosimilar HLX15-SC
PremiumCompany Announcements
Henlius Wins U.S. FDA IND Nod for Multiple Myeloma Biosimilar HLX15-SC
10d ago
2696
Henlius Wins NMPA Nod to Start Trials of Daratumumab Biosimilar HLX15-SC
PremiumCompany Announcements
Henlius Wins NMPA Nod to Start Trials of Daratumumab Biosimilar HLX15-SC
13d ago
2696
Henlius Starts Phase 1b/2 Trial of HLX43 Combinations in Advanced Colorectal Cancer
PremiumCompany Announcements
Henlius Starts Phase 1b/2 Trial of HLX43 Combinations in Advanced Colorectal Cancer
14d ago
2696
Henlius Grants Eisai Japan Rights to Flagship Cancer Drug HANSIZHUANG in Lucrative Licensing Deal
PremiumCompany Announcements
Henlius Grants Eisai Japan Rights to Flagship Cancer Drug HANSIZHUANG in Lucrative Licensing Deal
20d ago
2696
Shanghai Henlius Completes Full Circulation of H Shares on Hong Kong Stock Exchange
PremiumCompany AnnouncementsShanghai Henlius Completes Full Circulation of H Shares on Hong Kong Stock Exchange
21d ago
2696
Henlius Wins NMPA Nod for Triple-Drug Cancer Combination Trial Centered on HLX43
Premium
Company Announcements
Henlius Wins NMPA Nod for Triple-Drug Cancer Combination Trial Centered on HLX43
29d ago
2696
Henlius Wins NMPA Nod to Trial Novel CD47-Targeting Fusion Protein in Advanced Colorectal Cancer
Premium
Company Announcements
Henlius Wins NMPA Nod to Trial Novel CD47-Targeting Fusion Protein in Advanced Colorectal Cancer
1M ago
2696
Henlius Wins HKEX Approval for Full Circulation of 182.6 Million H Shares
PremiumCompany Announcements
Henlius Wins HKEX Approval for Full Circulation of 182.6 Million H Shares
1M ago
2696
Henlius Biotech Cleared by CSRC to Proceed With H Share Full Circulation
PremiumCompany Announcements
Henlius Biotech Cleared by CSRC to Proceed With H Share Full Circulation
1M ago
2696
Henlius Wins FDA Acceptance of BLA for Bevacizumab Biosimilar HANBEITAI
PremiumCompany Announcements
Henlius Wins FDA Acceptance of BLA for Bevacizumab Biosimilar HANBEITAI
1M ago
2696
Henlius Renews Key Fosun-Linked Leasing, Financial and Promotion Deals
PremiumCompany Announcements
Henlius Renews Key Fosun-Linked Leasing, Financial and Promotion Deals
2M ago
2696
Henlius Shareholders Approve Renewal of Sinopharm Distribution Framework Agreement
PremiumCompany AnnouncementsHenlius Shareholders Approve Renewal of Sinopharm Distribution Framework Agreement
2M ago
2696
Shanghai Henlius Doses First Patient in Phase 1 Trial of PD-L1/VEGF Bispecific HLX37
Premium
Company Announcements
Shanghai Henlius Doses First Patient in Phase 1 Trial of PD-L1/VEGF Bispecific HLX37
2M ago
2696
Henlius Wins FDA Clearance to Start US Trial of Nivolumab Biosimilar HLX18
Premium
Company Announcements
Henlius Wins FDA Clearance to Start US Trial of Nivolumab Biosimilar HLX18
2M ago
2696
Shanghai Henlius Biotech’s Gastric Cancer Treatment Gains Priority Review in China
PremiumCompany Announcements
Shanghai Henlius Biotech’s Gastric Cancer Treatment Gains Priority Review in China
3M ago
2696
Shanghai Henlius Biotech Advances Cancer Treatment Trials
PremiumCompany Announcements
Shanghai Henlius Biotech Advances Cancer Treatment Trials
3M ago
2696
Shanghai Henlius Biotech’s FUTUONING Added to National Drug List
PremiumCompany Announcements
Shanghai Henlius Biotech’s FUTUONING Added to National Drug List
3M ago
2696
Shanghai Henlius Biotech Expands Breast Cancer Portfolio Through Avanc Pharma Collaboration
PremiumCompany Announcements
Shanghai Henlius Biotech Expands Breast Cancer Portfolio Through Avanc Pharma Collaboration
3M ago
2696
Shanghai Henlius Biotech Renews Sinopharm Distribution Agreement
PremiumCompany AnnouncementsShanghai Henlius Biotech Renews Sinopharm Distribution Agreement
3M ago
2696
Shanghai Henlius Biotech to Hold EGM for Sinopharm Agreement Approval
Premium
Company Announcements
Shanghai Henlius Biotech to Hold EGM for Sinopharm Agreement Approval
3M ago
2696
Shanghai Henlius Biotech’s HLX14 Biosimilar Gains NMPA Acceptance
Premium
Company Announcements
Shanghai Henlius Biotech’s HLX14 Biosimilar Gains NMPA Acceptance
3M ago
2696

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >